From NADPARK to NOPARK

From NADPARK to NOPARK
# # # # Researchers in Norway recently published the results of a small pilot study investigating the therapeutic potential of a form of Vitamin B3 – called nicotinamide riboside – in people with Parkinson’s. The results of that randomised, double-blind study were encouraging as they demonstrated that orally-administered nicotinamide riboside treatment could boost energy levels in the brain ... read more
Source: The Science of Parkinson’s diseasePublished on 2022-03-11By Simon